Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly (NYSE:LLY), a major pharmaceutical company listed on the S&P 500 and NYSE Composite, continues to attract attention with developments across its legal, research, and expansion efforts. As ...

The stock's fall snapped a four-day winning streak.

Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition costs. Learn more about LLY stock here.

Shares of Eli Lilly & Co. LLY advanced 1.61% to $725.22 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.05% to 5,921 ...

The S&P 500 climbed 0.13% to end the session at 5,282.70 points. The Nasdaq declined 0.13% to 16,286.45 points, while the Dow Jones Industrial Average declined 1.33% to 39,142.23 points.

Eli Lilly down 19% in May, worst month since 2009. Underperformed S&P 500 by 24%, worst since August 2000. June shows promise, historically Lilly’s strongest month. From tariffs to inflation ...

The damage continues and about 80% of the S&P 500 companies were in red this week. ... Pharmaceutical company Eli Lilly is known as one of the best pharma plays to bet your money on. It is ...

Shares of Eli Lilly jumped 16% Thursday morning to lead S&P 500 gainers after the pharmaceutical company released clinical trial results for its oral weight-loss drug that "demonstrated ...

Concentration levels in the S&P 500 are at their highest levels since 1932. ... Eli Lilly: $770 billion; AAPL Total Return Level data by YCharts. With the exception of Berkshire and Lilly, ...